Fundraising Fox

Morphogenesis

Tampa, US · Founded 2023 · Delaware corporation

Biotech

Founders & leadership

Morphogenesis was founded in 2023 by Patricia Dianne Lawman and Michael John Lawman.

PD
Patricia Dianne LawmanCo-founder
MJ
Michael John LawmanCo-founder
SS
Scott SlaytonExecutive

Board

DB
David BergmannBoard director
DL
David LawmanBoard director
GC
Grahame CookBoard director

Reported raises · per SEC filings

Form D private placements

$22.9M disclosed across 6 of 7 rounds · 2017–2023

▶$1.7MraisedDec 2023 · 8 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Patricia LawmanDirector
  • Dan DearbornExecutive Officer
  • George NgDirector
  • Alan ListDirector
  • James BiancoExecutive Officer, Director
  • James ManusoDirector
  • Kiran PatelDirector
  • Michael LawmanDirector
Offering amount
$15M
Amount sold
$1.7M
Sales commissions
$133.2K
Placement agents
Paulson Investment Company LLC
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$9.1MraisedJul 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LawmanDirector
  • Patricia LawmanDirector
  • James BiancoExecutive Officer, Director
  • George NgDirector
  • Kiran C. PatelDirector
  • Dan DearbornExecutive Officer
Offering amount
$20M
Amount sold
$9.1M
First sale
Jun 2022
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedNov 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James BiancoExecutive Officer, Director
Amount sold
$5.1M
First sale
Oct 2021
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedSep 2021 · 39 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George NgDirector
  • Kiran PatelDirector
  • James BiancoExecutive Officer, Director
  • Daniel DearbornExecutive Officer
Offering amount
$11M
Amount sold
$3.8M
Sales commissions
$304.4K
Proceeds to insiders
$378K
Placement agents
Paulson Investment Company, LLC
First sale
Oct 2020
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$495KraisedJul 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph ErricoDirector
  • James McNultyDirector
  • Michael ShamblottExecutive Officer
  • Dan DearbornExecutive Officer
  • Patricia LawmanExecutive Officer, Director
  • Michael John LawmanExecutive Officer, Director
  • David BergmannDirector
  • Peter StaatsDirector
  • Kiran PatelDirector
Offering amount
$15M
Amount sold
$495K
Sales commissions
$1.2M
Placement agents
Skyway Capital Markets, LLC, Paulson Investment Company, LLC
First sale
Jun 2019
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedJan 2018 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David BergmannDirector
  • David LawmanDirector
  • Patricia Dianne LawmanExecutive Officer, Director
  • Grahame CookDirector
  • Scott SlaytonExecutive Officer
  • Michael John LawmanExecutive Officer, Director
Offering amount
$15M
Amount sold
$2.7M
Sales commissions
$1.2M
Proceeds to insiders
$376K
Placement agents
Skyway Capital Markets, LLC, Paulson Investment Company, LLC
First sale
Aug 2017
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MofferedApr 2017 · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Michael John LawmanExecutive Officer, Director
  • David LawmanDirector
  • Scott SlaytonExecutive Officer
  • David BergmannDirector
  • Grahame CookDirector
  • Patricia Dianne LawmanExecutive Officer, Director
Offering amount
$5M
Minimum investment
$10K
Sales commissions
$250K
Finders' fees
$250K
Proceeds to insiders
$305K
Placement agents
TBD
Incorporated
Corporation, Florida
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

One year in, the CEO of Tampa's Morphogenesis talks about its $22M in funding and the journey to going public - Tampa Bay Business Journalbizjournals.com · Jul 2022Morphogenesis Awarded SBIR Funding for Cervical Cancer Therapy - UF Innovateinnovate.research.ufl.edu · Jun 2021Tampa Florida based Morphogenesis is raising $11,000,000.00 in New Equity Investment. - intelligence360intelligence360.news · Jan 2021Morphogenesis, Inc. Raises $16M to Advance into Human Clinical Trials (BioFlorida) - UF Innovateinnovate.research.ufl.edu · May 2018Skyway Capital Markets | Morphogenesis Inc Raises 16Mskywaycapitalmarkets.com · May 2018

Frequently asked questions

Who founded Morphogenesis?
Morphogenesis was founded by Patricia Dianne Lawman, Michael John Lawman in 2023.
How much funding has Morphogenesis raised?
Morphogenesis has disclosed $22.9M raised across 6 of its 7 known rounds.
Where is Morphogenesis headquartered?
Morphogenesis is headquartered in Tampa, US.